GLPwatch
Trials (2167)
Page 27 of 37.
- Liraglutide in the Prevention of Type 2 Diabetes After Gestational Diabetes
- Assessment of the Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Insufficiently Controlled With Basal Insulin +/- Metformin
- Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes
- Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients
- A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
- Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
- GLP-1 Receptors in Normal Skin and Skin From Patients With Psoriasis
- A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability and Pharmacokinetics of Liraglutide in Obese Adolescent Subjects Aged 12 to 17 Years
- Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Saudi Arabia, as Part of Local Clinical Practice
- Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics
- The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus
- A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity
- A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
- Blood Pressure Outcomes With Liraglutide Therapy
- Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)
- Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without Metformin
- Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older Adults
- Influence of Appetite Related Hormones in Binge Eating Behaviour Among the Overweight and Obese
- Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal Insulins
- Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes Mellitus
- Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?
- A Study of Orforglipron (LY3502970) in Chinese Participants With Obesity or Overweight and Weight-Related Health Problems
- Effect of Liraglutide on Microbiome in Obesity
- A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
- Semaglutide for the Treatment of Cognitive Dysfunction in Major Depressive Disorder
- A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 Diabetes
- A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight
- A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
- Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity
- Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes
- Non-Interventional Study on Safety of Liraglutide in Subjects With Type 2 Diabetes
- O-SEMA-Fast: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Plan to Fast During Ramadan in the United Arab Emirates, Saudi Arabia, and Kuwait
- GLP-1 Agonism Stimulates Browning of Subcutaneous White Adipose Tissue in Obesity Men
- Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue
- A Study of BGM0504 in Chinese Patients With Type 2 Diabetes
- A Study Evaluating Safety and Tolerability of Switching From Semaglutide to Zovaglutide in Adults With Obesity (HORIZON-SWITCH-SZ)
- Natriuretic Effect of GLP-1in Healthy Non Obese Subjects
- To Predict Weight Loss Response to Liraglutide (Saxenda®), From fMRI-based Determination of Food Cue Reactivity
- Simplification of Complex Insulin Regimens With Preserving Good Glycemic Control in Type 2 Diabetes
- Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer
- Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese
- A Study to Evaluate ITCA 650 Compared to Glimepiride for the Treatment of Type 2 Diabetes
- Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes
- Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer
- 2024 Tirzepatide-Bariatric Surgery
- GLP-1 REceptor Agonists and Real World EvIdeNce
- The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
- Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes
- Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM
- Study of RO6807952 in Patients With Diabetes Mellitus Type 2
- Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM)
- Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents
- A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin
- A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabetes
- Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)
- Non-interventional, Post Marketing Surveillance Study of Xultophy™ (Insulin Degludec/Liraglutide) to Evaluate Long Term Safety and Efficacy in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in India
- Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)
- Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes